Advertisement
Advertisement
AXSM
Axsome Therapeutics, Inc
129.10
USD+8.43
+6.53%
Feb 21, 16:00 UTC -5
Closed
After-Market
138.529
+9.43
+7.30%
Axsome Therapeutics, Inc Profile
About
Info & Links
CEO
Herriot Tabuteau
Headquarters
NEW YORK, NY 10007, UNITED STATES
Industry
Sector
Website
Auditor
Deloitte & Touche LLP
Share holders
2
Employees
545
Axsome Therapeutics, Inc Statistics
Valuation Measures
Market Capitalization2
6.71B
Enterprise Value
6.57B
Enterprise Value/EBITDA(ttm)
-22.18
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
16.32
Price to Book(mrq)
109.73
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
91.36%
Operating Margin(ttm)
-57.49%
Profit Margin(ttm)
-76.73%
Return on Equity(ttm)
-223.51%
Return on Invested Capital(ttm)
-103.44%
Return on Assets(ttm)
-39.88%
Income Statement
Revenue(ttm)
338.46M
Revenue Per Share(ttm)
6.98
Gross Profit(ttm)
308.29M
EBITDA(ttm)3
-296.21M
Net Income Available to Common(ttm)
-310.95M
Diluted EPS(ttm)
-5.99
Share Statistics
Beta (5Y Monthly)
1.05
52-Week Change
60.43%
S&P 500 52-Week Change
18.16%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
48.46M
Dividend Yield
0.00%
Float4
37.84M
% Held by Insiders
22.40%
% Held by Institutions
81.49%
Balance Sheet
Total Cash(mrq)
327.34M
Total Cash Per Share(mrq)
6.75
Total Debt(mrq)
182.95M
Total Debt/Equity(mrq)
322.11%
Current Ratio(mrq)
2.11%
Quick Ratio(mrq)
2.37%
Book Value Per Share(mrq)
1.17
Cash Flow
Operating Cash Flow Per Share(ytd)
-2.68
Free Cash Flow(ytd)
-128.68M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
- 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
- 2 Market Cap is calculated using total shares outstanding and the most recent share price.
- 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
- 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement